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Study of individual erythrocyte 
deformability susceptibility 
to INFeD and ethanol using a 
microfluidic chip
Lihong Liu1,2,*, Sha Huang2,*,†, Xiaoying Xu1 & Jongyoon Han2,3
Human red blood cells (RBCs) deformability in vitro was assessed during iron dextran (INFeD) loading 
and/or ethanol co-administration using microfluidic deformability screening. The results showed donor-
specific variations in dose dependent deformability shift were revealed below 500 μg/mL iron dextran. 
Two out of nine blood samples exhibited significant cell stiffening at 500 μg/mL iron dextran loading 
concentration (p < 0.05, Tukey test). More interestingly, co-administration of moderate amount of 
ethanol was identified to have significant protective effects on RBC deformability. We also noted that 
ethanol can reverse the deformability of impaired RBCs. Meanwhile obvious donor dependent response 
to ethanol administration on RBC deformability was noted using our biomimetic microfluidic chip.
The ability of RBCs to deform plays an important role for effective blood microcirculation. The biconcave shape 
of RBCs (8-μm-diameter) is well known to allow RBCs to have a high flexibility and to pass through small blood 
capillaries and thin slits of splenic sinusoids. Compromised RBC deformability could induce risks relating to 
blood blockage or excessive mechanical clearance of RBC in spleen1. Given the important role of RBC deform-
ability, several approaches have been used in the past to assess RBC deformability as follows. Previously, the 
deformability of the healthy and iron deficient blood samples were compared by passing RBCs through 5 μm 
filters2, or determining RBC elongation index (EI) using a laser diffraction viscometer (i.e. ektacytometer)3,4. 
However, most of these clinical studies relied on data from completely different patient pools, failing to address 
the notably inherent inter-individual variability from different blood donors. Furthermore, these measurements 
revealed only bulk RBC deformability, failing to provide single-cell level information. Ability to monitor minor 
population of RBCs with abnormal deformability is important, since lysis/rupture of these RBCs can be the 
source of downstream complications.
Parenteral iron dextran (INFeD) has been used to iron stores replete in patients on chronic hemodialysis, with 
chronic gastrointestinal losses, and in surgical patients refusing blood transfusion. However 26% of patients expe-
rience side-effects, most of them all are mild, but 3% patients have more severe symptoms5. Despite adverse reac-
tions, INFeD is still an effective iron repletion therapy that is widely used in patients with iron-deficiency anemia. 
Therefore INFeD is chosen as model drug in our study. The mechanism(s) leading to INFeD-induced symptoms 
remains unclear but is probably multifactorial. Hamstra et al. found that severe reactions were associated with 
infusion of larger iron doses (more than 500 mg (iron, ~100 μg/mL))6. However, patients with chronic kidney dis-
ease generally received INFeD at a median dose of 1000 mg (iron, ~200 μg/mL))7 indicating that side-effects were 
more prevalent in young women, especially those with pre-existing collagen vascular disease5. Hypersensitivity to 
dextran or direct toxic effects of iron were implicated as the likely causes of adverse reactions to INFeD in patients 
with collagen vascular disease6.
Although extensive research has been carried out exploring the biochemical effect on RBCs, to the best of our 
knowledge, the patient-specific effect of INFeD on single RBC deformability remain under-explored. From the 
perspective of RBC deformability, ethanol exhibits a dose-dependent biphasic effect8. However, it is also unclear 
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whether moderate ethanol consumption could protect individuals from INFeD induced injury through improv-
ing RBC deformability.
A rapid blood deformability assay that assesses the differential INFeD induced deformability response on 
the same individual is therefore highly desirable. Therefore, we propose to study INFeD induced injury and 
ethanol protection on RBC mechanical deformability by a simple microfluidic platform (Fig. 1) which mimics 
RBC microcirculation in real blood capillary and captures hundreds of RBCs in a few minutes. Our chip involves 
periodically spaced, triangle-shaped pillars, and the constrictions in series along the length of the channel enable 
repeated measurements of the same cell, increasing precision. RBC deformability is dynamically quantified by 
measuring the average transit velocity of single red cell passing the repeated constrictions. The higher transit 
velocity corresponds to better deformability. Detailed fabrication steps were described by Bow et al.9. Due to 
diverse inter-individual susceptibility to INFeD and ethanol loading (Fig. 1), the same prescribed dose could lead 
to different effects on different individuals10. The same device has previously used for monitoring malaria infected 
RBC stiffening11, blood storage legion12 and spleen filterability of RBCs13.
Results
We investigated that the effect of INFeD loading on RBC deformability (Fig. 2). Fresh blood from nine healthy 
subjects (subject A–I, Fig. 2) were treated with 0.5–5000 μg/mL of INFeD solution in vitro and the deformability 
of single RBCs was characterized by their transit velocity when passing through the microfluidic deformability 
cytometer11. At the highest INFeD loading concentration (5000 μg/mL), significant RBC stiffening was observed 
for all blood samples (p < 0.05, Tukey test). Two out of nine blood samples exhibited significant cell stiffening 
at lower INFeD loading concentration (500 μg/mL, p < 0.05, Tukey test). One blood sample showed significant 
stiffening even at the lowest INFeD concentration (Subject D, Fig.2, p < 0.05, Tukey test).
Given that ethanol displays a dose dependent biphasic effect on normal RBC deformability14, we also inves-
tigated whether the damaging effect of INFeD overloading on RBC deformability could be reduced or tapered 
with carefully controlled ethanol co-administration. The results showed co-administration of small amount of 
Figure 1. Experimental schematics. (a) The PDMS chip consists of repeated pillar array structures and main 
channels with triangular pillar arrays. The microfluidic device was driven by a constant pressure gradient across 
(0.36 Pa/μm). (b) Experimental images of RBCs traveling in channels. (c) RBC deformability: control, without 
any treatment; INFeD, only 5000 μg INFeD treatment ; INFeD + 0.03% ethanol, with 5000 μg INFeD and 0.03% 
ethanol treatment; INFeD + 3% ethanol, with 5000 μg INFeD and 3% ethanol treatment . INFeD and ethanol 
were added to the RPMI solution containing 20% FBS with 1% hematocrit. All samples were incubated at 37 °C 
for 6 h.
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ethanol is found to improve RBC deformability (Fig. 3), morphology (Fig. 4b,c) against INFeD overloading. And 
our data suggests an interesting dose-dependent protective effect of ethanol on RBCs from INFeD induced injury. 
Ethanol was co-administrated at 0.03–3% v/v. In two out of six samples, a significant increase in RBC deformabil-
ity was detected when 0.03% of ethanol was co-administrated with INFeD (Fig. 3, subject L and N). In two other 
subjects, increase in RBC deformability only occurred at slightly higher ethanol concentration of 0.3% (Fig. 3, 
subject J and M), whereas in both subject K and O, an increasing trend seemed to appear after 0.03–0.3% of etha-
nol co-treatment, but not statistical significance can be concluded (Fig. 3, subject K and O, p > 0.05, Tukey test).
Fig. 4 illustrates how INFeD-treated RBC morphology can change with varied ethanol concentrations: 
whereas stomatocytes are typically formed with INFeD treatment alone (Fig. 4a), low concentration of ethanol 
co-administration (< 0.3% v/v) could preserve the discoid shape of normal RBCs to a large extent (Fig. 4b,c). 
However significant echinocytosis was observed among over 90% of RBC populations when 3% ethanol was 
added (Fig. 4d). The improvement or deterioration of RBC morphology also was observed in parallel with whole 
cell deformability. However, too much ethanol (i.e. 3% v/v or above) can lead to marked cell deterioration and is 
not desirable.
To further explore the ethanol related mechanism in which RBCs can be protected from INFeD induced dam-
age, additional experiments with three healthy blood samples (Subjects P–R) were performed and ethanol was 
only administered 2 h after 6 h INFeD loading (Fig.5). Cell deformability restoration was observed with 0.03% 
ethanol treatment (subjects P and Q), which is very similar to that of ethanol co-administration experiments 
(p < 0.05). High ethanol concentration would reversely lower RBC deformability. The result suggests appropriate 
amount of ethanol not only protects but also restores RBC from INFeD induced mechanical damage. In addition, 
confocal laser scanning microscope (CLSM) imaging (Fig. 6) was also presented to show the change of erythro-
cyte membrane skeleton. The results indicated that the distribution of actin on membrane skeleton of RBCs with 
INFeD was discrete and the actin duplex is uncoiled. low concentration of ethanol administration (< 0.3% v/v) 
after 6 h INFeD loading could partly recovered the actin of RBCs membrane skeleton and the content of actin was 
increased and evenly distributed in RBCs. However, 3% v/v ethanol brought about a lack of the actin resulting in 
an incomplete ring.
To further investigate the effect of ethanol on RBCs deformability, only ethanol with different concentra-
tions was used to treat the RBCs at 37 °C for 2 h. The effects appeared to be subject-dependent and very diverse 
Figure 2. INFeD dose dependent changes in RBC deformability in all 9 subjects (A–I). Each dot represents a 
cell. The grayed areas are the INFeD concentrations which induce the RBCs deformability significant difference 
compare to control deformability. Velocity measurement is normalized against the average RBC velocity in the 
control sample. The samples with different concentration INFeD were incubated at 37 °C for 6 h.
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(Fig. 7). At 3% v/v ethanol loading, in two subjects (T and V), a significant increase in RBC deformability was 
detected (p < 0.05, Tukey test). Sonmez et al.8 have reported the similar result. To note, in subject T, increase in 
RBC deformability occurred at slightly higher ethanol concentration of 0.3% (p < 0.001, Tukey test). However, 
in two other subjects (subject S and U), not statistical significance can be concluded. It is definitely true that the 
observed effect is subject-dependent and complicated, and this is one of the reason why a rapid measurement of 
RBC-response to drug and ethanol would be useful in clinical setting, quickly determining potential of effect for 
a particular patient/subject.
Discussion
In vitro, red blood cells cannot release iron from dextran. Iron chelated by dextran does not harm red blood 
cells to change the deformability. Therefore, the underlying mechanism of significant RBC stiffening at high 
concentration may be related to dextran. Dextrans specifically have been shown to adsorb to the RBC cell sur-
face, whereas soft surfaces, such as the RBC glycocalyx, are characterized by a layer of attached macromolecules 
that can be penetrated in part or entirely by the free polymer in solution15. Goldsmith and Marlow’ have sug-
gested that dextran may alter the mechanical or interfacial properties of the red cell membrane. But the cells in 
their study didn’t undergo extensional deformation16. Gerard B. Nash indicate that dextran has no effect on the 
elastic modulus and only a minimal influence on cell volume and surface area, but they found dextran induced 
a discocyte-stomatocyte shape transformation17, which has been discovered at higher INFeD concentration in 
our study. In addition, dextran can increase media osmotic pressures. The RBC deformability will decrease with 
increasing osmolality18. The differential dose-dependent deformability response in our study, therefore, is likely 
to be associated with individual’s cells susceptibility against INFeD overloading.
The possible mechanism accounting for the dose dependency of ethanol mediated cell damage is that at low 
concentration, alcohol molecules mainly situated on membrane surface, leading to an increase in lipids mobility17 
and alcohol can activate the protein kinase A and protein kinase C of the RBCs with mechanical stress, accord-
ingly improve the decreased filterability of RBCs. At higher concentration (3% v/v) however, alcohol molecules 
are pushed towards inner layers of the membrane, into the hydrophobic core, which then results in an expansion 
in the cytoskeleton19. Spectrin, an important cytoskeletal protein20 strongly associated with RBC morphology 
and deformability21, is located at the inner membrane of the red cells22. Previous study has reported that, with 
high concentration of ethanol radical, spectrin showed the highest loss among all other membrane protein23. 
Furthermore, studies also found that high concentration of ethanol could alter the osmolality of suspending 
medium, and thereby promotes the formation of echinocytosis (Fig. 4d)9. Additionally, at 3%, the destructive 
effect of ethanol could dominate: ethanol radicals was found to form covalent bonds with Hb24, which irreversibly 
Figure 3. RBC deformability are measured to investigate the effect of ethanol co-administration. 6 subjects 
(J–O) were assessed for this effect. The sample treament method is same as Fig. 1c. The blue star denoted the 
significant difference of RBCs deformability of ethanol with 5000 μg/mL INFeD treatment samples compare to 
5000 μg/mL INFeD treatment samples only.
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Figure 4. SEM imagings of RBCs with 5000 μg/mL INFeD only (a), 5000 μg/mL INFeD with different 
concentrations of ethanol (b–d) and with no treatment at all (e), Eth: ethanol.
Figure 5. The effect of ethanol on RBC deformability after INFeD (subjects (P–R)). RBC sample solutions 
containing 5000 μg/mL of INFeD were first incubated at 37 °C for 6 h, and then excess INFeD in the solution 
was removed. Different concentrations of ethanol were added to respective samples and incubate at 37 °C for 
another 2 h. The blue star denoted the significant difference of RBCs deformability of ethanol treatment samples 
after 5000 μg/mL INFeD compare to 5000 μg/mL INFeD treatment samples only.
www.nature.com/scientificreports/
6Scientific RepoRts | 6:22929 | DOI: 10.1038/srep22929
alters the hemoglobin structure. Nevertheless, ethanol radicals and iron oxidation exhibit much milder destruc-
tive chemical effect on RBC Hb as compared to the hydroxyl radicals1, though all induce metHb formation. While 
the mechanistic study of RBC deformability is generally challenging, the ability to rapidly measure such changes 
Figure 6. CLSM imaging of of erythrocyte membrane skeleton with 5000 μg/mL INFeD only (a), different 
concentrations of ethanol after 5000 μg/mL INFeD (b–d), and no treatment at all (e).
Figure 7. The effect of only ethanol on RBC deformability (subjects (S–V)). 1% RBC solution was made into 4 
aliquots containing 0, 0.03, 0.3 and 3% v/v of ethanol,respectively. All samples were incubated at 37 °C for 2 h. 
The blue star indicated the significant difference of RBCs deformability of ethanol treatment samples compare 
to control.
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in response to commonly used compounds would be able to provide clinically useful information, which is the 
main point we would like to get across in this paper.
To note, the dose-dependent changes in RBC deformability we have compared thus far are based on a “nor-
malized value”, taking the values from control sample as normalized “1”. By doing so, we highlight the percent-
age change of cell deformability after INFeD loading, specific to individual donors. However, inevitably, this 
normalization procedure also overlooks inherent baseline deformability difference from different donors. We 
note a fairly wide range in the baseline RBC velocity with mean and standard deviation of 3.23 ± 1.09 units. This 
donor-dependent difference in RBC baseline deformability was also illustrated previously by comparing the red 
cell elongation index under constant shear stress25. We analyzed the changes in RBC velocity after 5000 μg/mL 
of INFeD loading as a function of their baseline velocity for all 18 subjects (subjects A–R). The INFeD induced 
changes of RBC deformability (Δv) exhibited a positive correlation with the initial or baseline RBC deformability 
(γ = 0.93, r2 = 0.86). A linear fitting with slope of 0.68 suggests that in average a 68% stiffening was observed for 
when subjects undergo INFeD loading.
Conclusion
Overall, high concentration INFeD infusion was observed to reduce RBC deformability in vitro in a dose depend-
ent, patient-specific manner. Significant variation in individual’s RBC deformability tolerance against INFeD was 
found and quantified. Besides, we also report, for the first time, that co-administration of ethanol, at a moder-
ate dose, can partially alleviate INFeD-mediated RBC deformability damage. Meanwhile, we find ethanol can 
improve impaired cell deformability. This has important implications for patients with lower RBC deformability, 
such as thalassemia. Looking forward, the low-cost and on-site determination of individual RBC deformability 
with microfluidic technology could provide an additional dimension of clinically relevant information.
Methods
Sample preparation. Fresh human blood was centrifuged at 300 g for 3 min to remove the plasma and buffy 
coat. Packed RBCs were then added into RPMI 1640 medium (BioWhittaker RPMI-1640, Lonza) containing 20% 
of fetal bovine serum (Gibco by life technologies) such that final RBC solution contains 1% of packed RBCs. RBC 
solutions without INFeD or ethanol treatment was used as the control. In the INFeD loading experiments, RBC 
solutions were incubated with 0.5–5000 μg/mL of INFeD (Sigma) at 37 °C for 6 h. At the end of incubation, sample 
solutions were then washed with RPMI solution containing 20% FBS to remove excess INFeD in the medium. To 
prepare sample solution for the experiments requiring ethanol co-administration, 1% RBC solution with 5000 μg 
INFeD was first prepared and made into 4 aliquots. Ethanol was then added within 5 min so that final sample 
contained 0, 0.03, 0.3 and 3% v/v of ethanol. All samples were incubated at 37 °C for 6 h. For experiments treating 
ethanol after INFeD, RBC sample solutions containing 5000 μg/mL of INFeD were first incubated at 37 °C for 6 h. 
At the end of incubation, all samples were washed 3 times with RPMI medium containing 20% FBS at 300 g for 
5 min to ensure any excess INFeD in the solution is removed. Different concentrations of ethanol were then added 
to respective samples and incubate at 37 °C for another 2 h. For all experimental conditions, at the end of the pro-
cedure, all samples were washed 3 times to remove excess INFeD or/and ethanol. RBCs were then resuspend with 
RPMI medium containing 20% FBS. Each RBC samples were divided into two parts, for deformability and metHb 
measurements. Sample solutions were adjusted with RPMI medium containing 20% FBS such that the final hema-
tocrit is 0.2–1% for all. Cell tracker orange (Invitrogen) standard staining protocol was followed for improved 
image visualization. Fresh human blood samples were purchased from research blood components, LLC (http://
researchbloodcomponents.com/). The study protocol was approved by American Association of Blood Banks. 
The methods were carried out in accordance with the approved guidelines. An IRB approved consent form is 
obtained from each donor.
Deformability measurement. The microfluidic device was designed with layout program and it consists 
of 500 μm × 500 μm inlet/outlet reservoirs and parallel capillary channels with triangular pillar arrays (Fig. 1a). 
Deformability device was mounted to the microscope (Olympus IX51, Center Valley, PA) connected to a CCD 
camera (Hamamatsu Model C4742-80-12AG). Approximately 3 μl of blood samples were loaded to reservoir of 
the microfluidic device. The inlet reservoir was connected to a vertically held 60-ml syringe which was partially 
filled with with RPMI medium containing 20% FBS buffer solution. A laminar flow was induced by gravity11,13,26. 
Images were automatically obtained by IPLab (Scanalytics, Rockville, MD) at 100 ms time interval and the 
post-imaging analysis was done using imageJ. Cell deformability is defined by the transit velocity of cells flowing 
in the microchannels. The velocity of individual RBCs was simulated with the following equation:
=velocity Displacement
Traverse time (1)
where displacement is the distance the cells moved; the traverse time is in seconds. Normalized velocity was cal-
culated by dividing the velocity of individual RBCs from various experimental conditions by the control group 
RBC velocity on the same experimental day.
RBC morphology imaging. RBCs were fixed with 0.1 M PBS containing 2.5% glutaraldehyde for 1 h, dehy-
drated with alcohol (30%, 50%, 70%, 90%, and 100%) and dried on the formvar membrane. All treatments were 
performed at room temperature. The cells were then coated with gold and placed into the Scanning Electronic 
Microscope (SEM) chamber. SEM images were obtained using an electron microscope with a voltage of 20 kV. 
(Philip XL30, FEI Company, Eindhoven, The Netherlands).
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CLSM imaging of of erythrocyte membrane skeleton. RBCs were prepared according to the exper-
imental protocol of fluorescent phallotoxins instruction (Cytoskeleton). In short, fix the sample in 3.7% for-
maldehyde solution in PBS over night at room temperature, and then wash three times with PBS. Resuspend 
the fixed RBCs in 0.1% Triton X-100 in PBS for 5 minutes. After wash three times with PBS, add 10 uL of 
Rhodamine-Phalloidin (500 ug/mL of methanolic stock solution) on cells and incubate for 60 minutes at 4 °C. 
Rapidly wash three times with PBS. Place each coverslip and view using CLSM (Olympus FV10i).
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